within Pharmacolibrary.Drugs.ATC.S;

model S01HA05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 6.666666666666667,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.0004,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Procaine is an ester-type local anesthetic historically used for infiltration and nerve block anesthesia. It is known under the trade name Novocain, but it is largely replaced in modern medicine due to its short duration of action and higher allergenic potential compared to amide anesthetics. Its use in ophthalmology or systemic administration is rare or obsolete.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters in healthy adults. No directly referenced clinical pharmacokinetic study data available for procaine as S01HA05 (ophthalmological use) or other systemic administration.</p><h4>References</h4><ol><li>Amanda K Sullins, Susan M Abdel-Rahman,Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.,Paediatric drugs,2013<a href='https://pubmed.ncbi.nlm.nih.gov/23529866/'>https://pubmed.ncbi.nlm.nih.gov/23529866/</a></li><li>Jarna Shah, Effrossyni Gina Votta-Velis, Alain Borgeat,New local anesthetics.,Best practice & research. Clinical anaesthesiology,2018<a href='https://pubmed.ncbi.nlm.nih.gov/30322458/'>https://pubmed.ncbi.nlm.nih.gov/30322458/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01HA05;
